ZEB2 and cancer: ZEB2 emerges as a prognostic predictive biomarker for CMS2 CRC, as confirmed by the inverse correlation between relapse-free survival and ZEB2 expression, which could be also relevant to identify cancers endowed with E/M traits and associated with high aggressiveness55.